INTERNATIONAL-SYMPOSIUM ON EARLY DOPAMINE AGONIST THERAPY OF PARKINSONS-DISEASE

被引:17
|
作者
KURLAN, R
机构
关键词
D O I
10.1001/archneur.1988.00520260092026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:204 / 206
页数:3
相关论文
共 50 条
  • [33] EFFECT OF DOPAMINE AGONIST (LERGOTRILE MESYLATE) THERAPY ON 24 HOUR SECRETION OF PROLACTIN IN TREATED PARKINSONS-DISEASE
    BELL, RD
    CARRUTH, A
    ROSENBERG, RN
    BOYAR, RM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (04): : 807 - 811
  • [34] THERAPY OF PARKINSONS-DISEASE
    DELWAIDE, PJ
    LOUVAIN MEDICAL, 1981, 100 (06): : 381 - 387
  • [35] THERAPY FOR PARKINSONS-DISEASE
    VONKUMMER, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (41) : 1581 - 1582
  • [36] FLUCTUATING PARKINSONS-DISEASE - TREATMENT WITH THE LONG-ACTING DOPAMINE AGONIST CABERGOLINE
    AHLSKOG, JE
    MUENTER, MD
    MARAGANORE, DM
    MATSUMOTO, JY
    LIEBERMAN, A
    WRIGHT, KF
    WHEELER, K
    ARCHIVES OF NEUROLOGY, 1994, 51 (12) : 1236 - 1241
  • [37] CQA 206-291 - A NOVEL DOPAMINE AGONIST IN THE TREATMENT OF PARKINSONS-DISEASE
    RASCOL, O
    FABRE, N
    TERAVAINEN, H
    POEWE, W
    LUCKING, C
    RINNE, U
    DUPONT, E
    HIRT, D
    HOYER, M
    LATASTE, X
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (04) : 303 - 311
  • [38] SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE
    BRAUN, A
    FABBRINI, G
    MOURADIAN, MM
    SERRATI, C
    BARONE, P
    CHASE, TN
    JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) : 41 - 50
  • [39] AGONIST SUBSTITUTION IN ADVANCED PARKINSONS-DISEASE
    GOETZ, CG
    SHANNON, KM
    TANNER, CM
    CARROLL, VS
    KLAWANS, HL
    NEUROLOGY, 1989, 39 (08) : 1121 - 1122
  • [40] THE RETINAL DOPAMINE SYSTEM IN PARKINSONS-DISEASE
    NGUYENLEGROS, J
    HARNOIS, C
    DIPAOLO, T
    SIMON, A
    CLINICAL VISION SCIENCES, 1993, 8 (01): : 1 - 12